Factor VII Overview Categories 11 Blood products and plasma substitutes11.2 Plasma fractions for specific use Page headings Overview Primary Characterstics Indications Pharmacokinetics Contraindications Drug Interactions Side Effects Dosage High Risk Groups Warning / Precautions Storage Conditions Interference in Pathology Brands of Factor VII Manufacturers of Factor VII Primary Characterstics Indications Back to top Pharmacokinetics Back to top Contraindications Back to top Drug Interactions Back to top Side Effects Back to top Dosage Factor VII's dosage details are as follows: Dose Single Dose Frequency Route Instructions Adult Dosage 70 to 90 mcg/kg80 (80)12 hourlyIVBolus injection over 2 to 5 min, then maintain hacmostaris every 2-3 hours.270 mcg/kg270 (270)As recommended.IVTo treat hemarthroses: Paedriatic Dosage (20kg) No data regarding the Paedriatic dosage details of Factor VII is available. Neonatal Dosage (3kg) No data regarding the neonatal dosage details of Factor VII is available. High Risk Groups Back to top Warning / Precautions Back to top Storage Conditions Back to top Interference in Pathology Back to top Brands / Trade Names of Factor VII Back to top Manufacturers of Factor VII in Pakistan Novo Back to top Previous Drug Generic - Next Drug Generic
Factor VII Overview Categories 11 Blood products and plasma substitutes11.2 Plasma fractions for specific use Page headings Overview Primary Characterstics Indications Pharmacokinetics Contraindications Drug Interactions Side Effects Dosage High Risk Groups Warning / Precautions Storage Conditions Interference in Pathology Brands of Factor VII Manufacturers of Factor VII Primary Characterstics Indications Back to top Pharmacokinetics Back to top Contraindications Back to top Drug Interactions Back to top Side Effects Back to top Dosage Factor VII's dosage details are as follows: Dose Single Dose Frequency Route Instructions Adult Dosage 70 to 90 mcg/kg80 (80)12 hourlyIVBolus injection over 2 to 5 min, then maintain hacmostaris every 2-3 hours.270 mcg/kg270 (270)As recommended.IVTo treat hemarthroses: Paedriatic Dosage (20kg) No data regarding the Paedriatic dosage details of Factor VII is available. Neonatal Dosage (3kg) No data regarding the neonatal dosage details of Factor VII is available. High Risk Groups Back to top Warning / Precautions Back to top Storage Conditions Back to top Interference in Pathology Back to top Brands / Trade Names of Factor VII Back to top Manufacturers of Factor VII in Pakistan Novo Back to top Previous Drug Generic - Next Drug Generic